Content is not available

TYME Inc.

Bedminster,  NJ 
United States
https://tymeinc.com/
  • Booth: 23135

TYME is an emerging biotechnology company focused on exploring novel therapeutic approaches to target cancer’s unique metabolism. To date, oral SM-88, our lead Cancer Metabolism-Based Compound (CMBTs™) has demonstrated clinical responses in 15 different cancer types across four separate studies. Oral SM-88 is being evaluated as a potential therapy for patients in prostate, pancreatic, and sarcomas. TYME is now enrolling patients in the TYME-88-Panc pivotal study for patients with third-line pancreatic cancer and HopES Sarcoma study. Learn more at TYMEtrials.com

 Press Releases

 Products

  • About TYME
    TYME is an emerging biotechnology company focused on exploring novel therapeutic approaches to target cancer’s unique metabolism. To date, oral SM-88, our lead Cancer Metabolism-Based Compound (CMBTs™) has demonstrated clinical responses in 15 different cancer types across four separate studies.

    Oral SM-88 is being evaluated as a potential therapy for patients in prostate, pancreatic, and sarcomas. TYME is now enrolling patients in the TYME-88-Panc pivotal study for patients with third-line pancreatic cancer and HopES Sarcoma study. Learn more at TYMEtrials.com...

Categories

Cancer Types
  • Gastrointestinal (Noncolorectal) Cancer
  • Genitourinary Cancer
  • Sarcoma/Bone and Soft Tissue Cancers
    • Categories:
  • Biotechnology
  • Clinical Trials
    • Back to the Search
    Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined